Related Experiment Videos
A CCR2-V64I polymorphism affects stability of CCR2A isoform
Emi E Nakayama1, Yuetsu Tanaka, Yoshiyuki Nagai
1Research Institute for Microbial diseases, Osaka University, Osaka, Japan.
AIDS (London, England)
|April 13, 2004
Summary
The CCR2-64I allele, linked to slower AIDS progression in HIV-1, increases CCR2A expression and cytoplasmic binding to CCR5. This interaction may reduce CCR5 surface levels, potentially delaying HIV-1 disease advancement.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- The CCR2-64I allele is associated with delayed AIDS progression in HIV-1 infection.
- Understanding the molecular mechanisms of this allele is crucial for HIV-1 research.
Purpose of the Study:
- To investigate the molecular mechanism by which the CCR2-64I substitution affects CCR2 expression and function.
- To elucidate how CCR2-64I influences CCR5 interaction and cell surface expression.
Main Methods:
- Analysis of CCR2A and CCR2B expression levels using Sendai virus vectors.
- Pulse-chase experiments to determine the half-life of CCR2A.
- Co-expression studies with CCR5 and immunoprecipitation assays.
Main Results:
- CCR2A-64I showed significantly higher expression and increased half-life compared to wild-type CCR2A.
- CCR2A, particularly the CCR2A-64I variant, was found to bind CCR5 in the cytoplasm.
- CCR2A-64I more severely interfered with CCR5 cell surface expression than wild-type CCR2A.
Conclusions:
- CCR2A binds to CCR5 in the cytoplasm, leading to down-modulation of CCR5 surface expression.
- The enhanced ability of CCR2A-64I to down-modulate CCR5 may contribute to the delayed HIV-1 disease progression observed in individuals with this allele.